Showing 641 - 660 results of 27,622 for search '(( 50 ((nn decrease) OR (we decrease)) ) OR ( 50 ((n decrease) OR (a decrease)) ))', query time: 1.02s Refine Results
  1. 641
  2. 642
  3. 643

    <i>Cyclocarya paliurus</i> extract activates insulin signaling via Sirtuin1 in C2C12 myotubes and decreases blood glucose level in mice with impaired insulin secretion by Hisae Yoshitomi (722082)

    Published 2017
    “…In addition, CPE enhanced tyrosine phosphorylation of insulin receptor substrate and activated phosphatidylinositol 3-kinase and protein kinase B (Akt) via sirtuin1 in C2C12 cells. Moreover, we found that oral administration of CPE (1 g/kg) to streptozotocin-induced hyperglycemic mice produced a progressive decrease in plasma glucose levels at 1 h after single dosing. …”
  4. 644
  5. 645
  6. 646
  7. 647

    Transient VEP loss due to manipulation of the optic nerve. by Yeda Luo (710942)

    Published 2015
    “…At 15:00, the VEP decrease reached the warning criterion (50%) and a warning was issued to the surgeon who consequently altered the surgical strategy. …”
  8. 648
  9. 649

    Relationship between OLT and soil temperature at 50-cm (a), the depth at which charcoal was measured (b), and the active layer depth (c) measured in the field for a subset of the d... by Kristofer D Johnson (557206)

    Published 2013
    “…</strong> Relationship between OLT and soil temperature at 50-cm (a), the depth at which charcoal was measured (b), and the active layer depth (c) measured in the field for a subset of the data (<em>n</em> = 2179). …”
  10. 650

    Compound CID 9998128 Is a Potential Multitarget Drug for Alzheimer’s Disease by Nguyen Quoc Thai (5348798)

    Published 2018
    “…We have probed small molecule compound CID 9998128 as a potential multitarget drug for the Alzheimer’s disease (AD) using <i>in silico</i> and <i>in vitro</i> experiments. …”
  11. 651

    Compound CID 9998128 Is a Potential Multitarget Drug for Alzheimer’s Disease by Nguyen Quoc Thai (5348798)

    Published 2018
    “…We have probed small molecule compound CID 9998128 as a potential multitarget drug for the Alzheimer’s disease (AD) using <i>in silico</i> and <i>in vitro</i> experiments. …”
  12. 652

    <i>N</i><sup>6</sup>-methyladenosine modification and the YTHDF2 reader protein play cell type specific roles in lytic viral gene expression during Kaposi's sarcoma-associated herp... by Charles R. Hesser (5147309)

    Published 2018
    “…<div><p>Methylation at the <i>N</i><sup>6</sup> position of adenosine (m<sup>6</sup>A) is a highly prevalent and reversible modification within eukaryotic mRNAs that has been linked to many stages of RNA processing and fate. …”
  13. 653
  14. 654
  15. 655
  16. 656
  17. 657
  18. 658
  19. 659
  20. 660